CSL Ltd (ASX:CSL) Stock News, Headlines & Updates
CSL Ltd Stock News from GuruFocus
- 1
May 23, 2025
England's NICE recommends FILSPARI® (sparsentan) as a treatment option for IgA nephropathy
PRNewswire • 4:00am
England's NICE recommends FILSPARI® (sparsentan) as a treatment option for IgA nephropathy | CSLLY Stock News
GuruFocus News • 3:15am
Apr 29, 2025
- 1
Show
Entries
Headlines
Total 0- 1
No recent news